cd56 pc 7 Search Results


anti-cd56 pc7  (Becton Dickinson)
90
Becton Dickinson anti-cd56 pc7
Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells <t>(CD56</t> + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).
Anti Cd56 Pc7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd56+pc+7/anti+cd56/pmc10296665-87-13-15
Average 90 stars, based on 1 article reviews
anti-cd56 pc7 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pc5 conjugated anti-cd56  (Immunotec inc)
90
Immunotec inc pc5 conjugated anti-cd56
Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells <t>(CD56</t> + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).
Pc5 Conjugated Anti Cd56, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd56+pc+7/anti+cd56/pmc03718138-229-11-14
Average 90 stars, based on 1 article reviews
pc5 conjugated anti-cd56 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
anti-cd20-pc5  (Becton Dickinson)
90
Becton Dickinson anti-cd20-pc5
Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells <t>(CD56</t> + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).
Anti Cd20 Pc5, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd56+pc+7/7+aminoactinomycin+d++7+aad/10__1128_slash_jvi__01801___14-52-52-54
Average 90 stars, based on 1 article reviews
anti-cd20-pc5 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
nkg2d (cd314) apc antibody  (Becton Dickinson)
90
Becton Dickinson nkg2d (cd314) apc antibody
Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells <t>(CD56</t> + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).
Nkg2d (Cd314) Apc Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd56+pc+7/anti+nkg2d/pm39332041-94-17-29
Average 90 stars, based on 1 article reviews
nkg2d (cd314) apc antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
phycoerythrin cyanine pc 5  (Beckman Coulter)
93
Beckman Coulter phycoerythrin cyanine pc 5
Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells <t>(CD56</t> + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).
Phycoerythrin Cyanine Pc 5, supplied by Beckman Coulter, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd56+pc+7/CD8-PC7+SFCI21Thy2D3+RUO/pm21264907-465-0-41
Average 93 stars, based on 1 article reviews
phycoerythrin cyanine pc 5 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
pc5-labeled anti-cd4  (Immunotec inc)
90
Immunotec inc pc5-labeled anti-cd4
Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells <t>(CD56</t> + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).
Pc5 Labeled Anti Cd4, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd56+pc+7/monoclonal+antibodies/pm17066321-66-26-44
Average 90 stars, based on 1 article reviews
pc5-labeled anti-cd4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells (CD56 + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).

Journal: Cancers

Article Title: CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)

doi: 10.3390/cancers15123169

Figure Lengend Snippet: Characterization of primary HNSCC (pHNSCC) cells. Characterization of ( A ) CD45 + immune cells present in isolated pHNSCC samples as well as ( B ) percentage of NK cells (CD56 + ), macrophages (CD11b + ), B cells (CD19 + ) and T cells (CD3 + ) of CD45 + cells in pHNSCC samples and ( C ) percentages of stroma cells (CD140a + ), endothelial cells (CD31 + ), cancer-associated fibroblasts (FAP + ) and epithelial marker-positive cells (EpCAM + ) in the CD45 − pHNSCC cell population within 24 h from isolation (or thawing). ( D ) Target antigen expression within 24 h of isolation (or thawing) of pHNSCC samples. ( E ) Quantitative analysis of immunohistochemical stainings of seven patient samples (photos from exemplary patient samples shown in ). ( F ) HER1 expression on EpCAM + sorted and expanded pHNSCC samples. Optical genome mapping of EpCAM + sorted and expanded pHNSCC samples ( G ) #14 and ( H ) #16. Red box highlights amplification of 11q13, (Legend: ● copy number gains (blue lines), ● copy number losses (red lines), ● insertions, ● deletions, ● inversions, ● duplications, ● intra-fusions or inter-translocations (pink lines)). Mean with standard deviation shown. n = 4–9 pHNSCC samples as indicated ( A – E ).

Article Snippet: Next, cells were incubated with anti-Flag PE (BioLegend, San Diego, CA, USA) and anti-CD56 PC7 (BD Biosciences, Franklin Lakes, NJ, USA).

Techniques: Isolation, Marker, Expressing, Immunohistochemical staining, Amplification, Standard Deviation